175 related articles for article (PubMed ID: 37314482)
1. Nε-(1-Carboxymethyl)-L-lysine, an advanced glycation end product, exerts malignancy on chondrosarcoma via the activation of cancer stemness.
Chang TY; Lan KC; Wu CH; Sheu ML; Yang RS; Liu SH
Arch Toxicol; 2023 Aug; 97(8):2231-2244. PubMed ID: 37314482
[TBL] [Abstract][Full Text] [Related]
2. Nε-(1-Carboxymethyl)-L-lysine/RAGE Signaling Drives Metastasis and Cancer Stemness through ERK/NFκB axis in Osteosarcoma.
Chang TY; Lan KC; Wu CH; Sheu ML; Yang RS; Liu SH
Int J Biol Sci; 2024; 20(3):880-896. PubMed ID: 38250151
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil-derived advanced glycation end products-Nε-(carboxymethyl) lysine promotes RIP3-mediated myocardial necroptosis via RAGE and exacerbates myocardial ischemia/reperfusion injury.
Yang J; Zhang F; Shi H; Gao Y; Dong Z; Ma L; Sun X; Li X; Chang S; Wang Z; Qu Y; Li H; Hu K; Sun A; Ge J
FASEB J; 2019 Dec; 33(12):14410-14422. PubMed ID: 31665609
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
[TBL] [Abstract][Full Text] [Related]
5. Nε-(carboxymethyl)lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistance.
Gaens KH; Goossens GH; Niessen PM; van Greevenbroek MM; van der Kallen CJ; Niessen HW; Rensen SS; Buurman WA; Greve JW; Blaak EE; van Zandvoort MA; Bierhaus A; Stehouwer CD; Schalkwijk CG
Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1199-208. PubMed ID: 24723555
[TBL] [Abstract][Full Text] [Related]
6. Nε-(carboxymethyl) lysine-induced mitochondrial fission and mitophagy cause decreased insulin secretion from β-cells.
Lo MC; Chen MH; Lee WS; Lu CI; Chang CR; Kao SH; Lee HM
Am J Physiol Endocrinol Metab; 2015 Nov; 309(10):E829-39. PubMed ID: 26394662
[TBL] [Abstract][Full Text] [Related]
7. The effects of low-dose nepsilon-(carboxymethyl)lysine (CML) and nepsilon-(carboxyethyl)lysine (CEL), two main glycation free adducts considered as potential uremic toxins, on endothelial progenitor cell function.
Zhu J; Yang K; Jing Y; Du R; Zhu Z; Lu L; Zhang R
Cardiovasc Diabetol; 2012 Aug; 11():90. PubMed ID: 22853433
[TBL] [Abstract][Full Text] [Related]
8. Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations.
Hammes HP; Brownlee M; Lin J; Schleicher E; Bretzel RG
Diabetologia; 1999 May; 42(5):603-7. PubMed ID: 10333054
[TBL] [Abstract][Full Text] [Related]
9. Role of Glycated High Mobility Group Box-1 in Gastric Cancer.
Kishi S; Nishiguchi Y; Honoki K; Mori S; Fujiwara-Tani R; Sasaki T; Fujii K; Kawahara I; Goto K; Nakashima C; Kido A; Tanaka Y; Luo Y; Kuniyasu H
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068442
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of the advanced glycation end product carboxymethyl lysine in breast cancer is positively associated with estrogen receptor expression and unfavorable prognosis in estrogen receptor-negative cases.
Nass N; Ignatov A; Andreas L; Weißenborn C; Kalinski T; Sel S
Histochem Cell Biol; 2017 May; 147(5):625-634. PubMed ID: 28012130
[TBL] [Abstract][Full Text] [Related]
11. Nε-carboxymethyl-lysine-induced PI3K/Akt signaling inhibition promotes foam cell apoptosis and atherosclerosis progression.
Wang Z; Bao Z; Ding Y; Xu S; Du R; Yan J; Li L; Sun Z; Shao C; Gu W
Biomed Pharmacother; 2019 Jul; 115():108880. PubMed ID: 31035012
[TBL] [Abstract][Full Text] [Related]
12. Specific local cardiovascular changes of Nepsilon-(carboxymethyl)lysine, vascular endothelial growth factor, and Smad2 in the developing embryos coincide with maternal diabetes-induced congenital heart defects.
Roest PA; Molin DG; Schalkwijk CG; van Iperen L; Wentzel P; Eriksson UJ; Gittenberger-de Groot AC
Diabetes; 2009 May; 58(5):1222-8. PubMed ID: 19188426
[TBL] [Abstract][Full Text] [Related]
13. Antibodies against advanced glycation end product Nepsilon-(carboxymethyl)lysine in healthy controls and diabetic patients.
Vay D; Vidali M; Allochis G; Cusaro C; Rolla R; Mottaran E; Bellomo G; Albano E
Diabetologia; 2000 Nov; 43(11):1385-8. PubMed ID: 11126407
[TBL] [Abstract][Full Text] [Related]
14. The advanced glycation end product Nepsilon-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes.
Berg TJ; Clausen JT; Torjesen PA; Dahl-Jørgensen K; Bangstad HJ; Hanssen KF
Diabetes Care; 1998 Nov; 21(11):1997-2002. PubMed ID: 9802757
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN).
Yuan Y; Sun H; Sun Z
Lipids Health Dis; 2017 Jun; 16(1):126. PubMed ID: 28659153
[TBL] [Abstract][Full Text] [Related]
16. Increased Nepsilon-(carboxymethyl)-lysine levels in cerebral blood vessels of diabetic patients and in a (streptozotocin-treated) rat model of diabetes mellitus.
van Deutekom AW; Niessen HW; Schalkwijk CG; Heine RJ; Simsek S
Eur J Endocrinol; 2008 May; 158(5):655-60. PubMed ID: 18426823
[TBL] [Abstract][Full Text] [Related]
17. The advanced glycation end-product N
Menini S; Iacobini C; de Latouliere L; Manni I; Ionta V; Blasetti Fantauzzi C; Pesce C; Cappello P; Novelli F; Piaggio G; Pugliese G
J Pathol; 2018 Jun; 245(2):197-208. PubMed ID: 29533466
[TBL] [Abstract][Full Text] [Related]
18. CML/CD36 accelerates atherosclerotic progression via inhibiting foam cell migration.
Xu S; Li L; Yan J; Ye F; Shao C; Sun Z; Bao Z; Dai Z; Zhu J; Jing L; Wang Z
Biomed Pharmacother; 2018 Jan; 97():1020-1031. PubMed ID: 29136780
[TBL] [Abstract][Full Text] [Related]
19. Dietary Intake of Nε-carboxymethyl-lysine, a Major Advanced Glycation End Product, is Not Associated with Increased Risk of Mortality in Japanese Adults in the Takayama Study.
Nagata C; Wada K; Yamakawa M; Nakashima Y; Koda S; Uji T; Oba S
J Nutr; 2020 Oct; 150(10):2799-2805. PubMed ID: 32840609
[TBL] [Abstract][Full Text] [Related]
20. Natural compounds containing a catechol group enhance the formation of Nε-(carboxymethyl)lysine of the Maillard reaction.
Fujiwara Y; Kiyota N; Tsurushima K; Yoshitomi M; Mera K; Sakashita N; Takeya M; Ikeda T; Araki T; Nohara T; Nagai R
Free Radic Biol Med; 2011 Apr; 50(7):883-91. PubMed ID: 21195168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
